Self-Discipline Covenant
Yuan Shu attended the kickoff meeting for the Qixia District’s initiative to enhance quality management system certification among small and micro enterprises.
Leaders from the Quality Department of Qixia District and certification experts from Jiangsu Tiangui visited our company to conduct a comprehensive audit and provide guidance on the operation of our quality management system.
Yuan Shu Pharmaceutical’s project, “Research and Development of Aromatic Hydrocarbon‑Based Drug Intermediates for Age‑Related Diseases,” has been approved as a proposed key R&D and technological innovation project for Qixia District in 2021.
YuanShu’s recommended premium product: N,N'-(2-Hydroxy-1,3-propanediyl)di[N-(2-hydroxyethyl)hexadecanamide]
YuanShu’s Featured Product Recommendation: Modified Bisphenol A Epoxy Resin
YuanShu’s recommended premium product: Coconut Acyl Chloride
YuanShu’s recommended premium product: 2-Bromo-1-(4-fluorophenyl)-2-phenylethanone
YuanShu’s recommended premium product: 2,6-Dichloro-3-carboxamido-5-fluoropyridine
YuanShu’s recommended premium product: 4-Fluorobenzoylacetonitrile
Yuan Shu successfully passed the re-examination for high-tech enterprise status.
Our company’s general manager paid a study visit to the Shenzhen Stock Exchange.
EASTMAN representatives paid a visit to our company for an exchange.
Yuanshu Pharmaceutical is set to participate in CPhI Shanghai 2020 (Booth No. E6E62).
Yuan Shu has successfully obtained an invention patent for a method of synthesizing and purifying 4-fluorobenzoylacetonitrile.
[Farshu Invention] A Method for the Synthesis and Purification of 4-Fluorobenzoylacetonitrile
Warmly celebrate the listing of Yuanshu Pharmaceutical Technology Co., Ltd. on the Science and Technology Innovation Board of the Jiangsu Equity Exchange Center.